NASDAQ:PRFX

Painreform Stock Predictions

Healthcare > Drug Manufacturers - Specialty & Generic

Buy PRFX

*Your capital is at risk

$1.86

-0.160 (-7.92%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

PRFX Prediction Chart

PRFX Predictions History

Latest community submissions for PRFX.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Oct 4, 2021	$2.89 -99.98%	$2.78	X	96.04%	0
phillyska.262058	Oct 4, 2021	Bullish	$2.78	X	—	1
JS Pro	Jul 26, 2021	$3.89 -99.98%	$3.33	V	83.18%	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for PRFX with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT PAINREFORM LTD.

PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the tre...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by